Navigation Links
Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug

Pfizer Inc announced an agreement with Schwarz Pharma AG under which it would be acquiring exclusive worldwide rights to fesoterodine, a new drug that can be a treatment option for an overactive bladder. //

"Overactive bladder is a debilitating condition that affects up to 100 million people around the world," said Karen Katen, vice chairman of Pfizer Inc and president, Pfizer Human Health. "We are excited about the potential of this new medicine to offer patients and their doctors a new alternative to existing therapies for managing the symptoms of overactive bladder." Schwarz had submitted an application for fesoterodine approval to both the US Food and Drug Administration and the European Medicines Evaluation Agency (EMEA) earlier this year. Initially Pfizer will pay $100 million to Schwarz Pharma. This amount can be increased provided the drug meets certain milestones. Royalties of both fesoterodine and Pfizer's Detrol product line for treatment of overactive bladder will be paid to Schwarz. Pfizer's Detrol LA is a leading drug that helps control involuntary bladder contractions and decreases the symptoms of urgency with or without frequency and incontinence. Since its introduction it has been prescribed to over 11 million patients worldwide.
'"/>




Page: 1

Related medicine news :

1. Pfizer unveils anti-smoking drug
2. The Effectiveness Of The Breast Cancer Drug By Pfizer
3. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
4. Erectile Dysfunction Drug Viagra Launched In India By Pfizer
5. Pfizer’s Eraxis Approved By The FD
6. Pfizer Launches Viagra For Lung Disease In UK
7. Pfizer Commences Its Advertising for Celebrex with All the Warnings
8. FDA Approves Pfizer’s Anti-smoking Dru
9. Pfizer vouches safety of long-term inhaled insulin.
10. NICE Setback Rules for Pfizers Inhaled Insulin
11. Patency On Two Drugs From Merck & Pfizer’s To Expire Soo
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug

(Date:9/18/2014)... It is almost time to park your Hyundai to ... happier kids. The South Florida Hyundai Dealers Association is ... Children’s Hospital 5K Run/Walk. Its title sponsor is Hyundai ... 5K will take place on Saturday August 20th. The ... City Hall located at 405 Biltmore Way. Registration is ...
(Date:9/18/2014)... Africa (PRWEB) September 18, 2014 Phela ... adopt the HABIT™ Program in South Africa. ... Health and Wellness, and distributed in South Africa by ... the HABIT program, which has been tailored to address ... HABIT™ focuses on behavior modification and chronic disease prevention. ...
(Date:9/18/2014)... in German . ... have won the ,International Space Station Research Competition, with ... prize, the scientists will see the International Space Station ... involves crystallizing two proteins of the hepatitis C virus ... the International Space Station is scheduled to lift off ...
(Date:9/18/2014)... PlatinumCode, a leading manufacturer and ... for the healthcare industry, announced earlier this month ... of their profits of the sale of eligible ... the announcement, PlatinumCode has launched various marketing efforts ... and hospital labs with their popular “Pink Packs” ...
(Date:9/18/2014)... T-System Inc. today announced Holyoke ... system — EV™ for physicians — ... several best-of-breed solutions, Holyoke chose T-System’s solution because ... productivity and reimbursement, but also its ability to ... be used to capture emergency department, (ED) nurse ...
Breaking Medicine News(10 mins):Health News:South Florida Hyundai Dealers Association Proudly Support the 4th Annual Miami Children’s Hospital 5K Run/Walk this Saturday August 20th in Coral Gables 2Health News:South Florida Hyundai Dealers Association Proudly Support the 4th Annual Miami Children’s Hospital 5K Run/Walk this Saturday August 20th in Coral Gables 3Health News:Hepatitis C virus proteins in space 2Health News:PlatinumCode Commits to Donating Five Percent of Profits from the sale of Pink Products to Support Breast Cancer Awareness 2Health News:Holyoke Medical Center ER Improves Productivity and Reimbursement with T-System 2
... , WASHINGTON , Jan. 14 Thirteen ... Department of Health and Human Services, Office of the Inspector General ... scheme to defraud the Medicare program of more than $14.5 ... of the Criminal Division; U.S. Attorney Barbara L. McQuade ...
... , NEWTON, Mass. , ... Centers for Medicare and Medicaid Services (CMS) will make ... acute-care settings to inpatient rehabilitation facilities (IRFs), according to ... building secure electronic patient-transition networks for hospitals, post-acute providers ...
... , National Sleep Foundation Launches Air Purification Product ... Jan. 14 The National Sleep Foundation (NSF) is ... leading indoor air cleaner manufacturer, to launch a new National ... environment.  The National Sleep Foundation Bedroom Machine by Austin Air ...
... advise people with medical conditions that could affect their ... wheel, according to research from the University of Warwick., ... many healthcare professionals are failing to tell patients with ... they are not fit to drive. In a ...
... doubled in young children, study finds , THURSDAY, Jan. ... vaccine for bacterial pneumonia was introduced in the United ... pneumonia because of pneumococcus has decreased by 50 percent ... , But the scientists also found a 70 percent ...
... ... of its new retail site, CoastToCoastMattress.com. CoastToCoastMattress.com is an e-commerce website dedicated to making ... United States. , ... (PRWEB) January 14, 2010 -- Coast To Coast Mattress is pleased to announce the ...
Cached Medicine News:Health News:Thirteen Detroit-Area Individuals Arrested and Charged for $14.5 Million Medicare Fraud 2Health News:Thirteen Detroit-Area Individuals Arrested and Charged for $14.5 Million Medicare Fraud 3Health News:Thirteen Detroit-Area Individuals Arrested and Charged for $14.5 Million Medicare Fraud 4Health News:2010: A Tough Year Ahead for Discharge Planners, but Help Is Available 2Health News:2010: A Tough Year Ahead for Discharge Planners, but Help Is Available 3Health News:National Sleep Foundation Partners With Austin Air Systems 2Health News:National Sleep Foundation Partners With Austin Air Systems 3Health News:National Sleep Foundation Partners With Austin Air Systems 4Health News:Health care professionals failing to tell patients they are not fit to drive 2Health News:Lung Infection Up in Wake of Kids' Pneumonia Vaccine 2Health News:Coast To Coast Mattress Announces the Grand Opening of CoastToCoastMattress.com 2
(Date:9/18/2014)... , Sept. 18, 2014  Zacks.com announces the ... day the Zacks Equity Research analysts discuss the latest ... Stocks recently featured in the blog include the Avanir Pharmaceuticals ... (Nasdaq: NPSP - Free Report ), Orexigen (Nasdaq: ... MDVN - Free Report ) and Gilead (Nasdaq: ...
(Date:9/18/2014)... Australia , Sept. 18, 2014 Veterinary ... of Dr. Ashraf Hanna , M.D., Ph.D., and ... Board of Directors. Dr. Hanna is the Vice President ... Chief Financial Officer for the Genentech Foundation, while Dr. ... Head of Business Development and Licensing for Roche Pharma. ...
(Date:9/18/2014)... , Sept. 18, 2014   Regulus Therapeutics ... biopharmaceutical company leading the discovery and development of ... initiated its ATHENA natural history of disease study ... kidney disease with no approved therapy. The ATHENA ... of renal function markers such as Glomerular Filtration ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 2The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 4The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 5The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 6Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 3Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 4Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 5Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 6
... , BOCA RATON, Fla., Nov. 16 CPG has ... Management (PLM) Release 9.3 at Avema Pharma Solutions, a division ... operation of pharmaceutical, over-the-counter (OTC), and nutritional solid-dose products based ... live at Avema on September 28, 2009. "As a contract ...
... , JAMAICA PLAIN, Mass., Nov. 16 ... presentation today at the AACR-NCI-EORTC International Conference Molecular Targets ... efficiently penetrates the blood brain barrier and may be ... Olaf van Tellingen, Ph.D. of The Netherlands Cancer Institute, ...
Cached Medicine Technology:CPG Implements First-Ever Agile PLM Release 9.3 at Avema Pharma Solutions 2Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics 2Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics 3
Titanium. Straight shafts with 6 mm platform and Pierse tips. Flat serrated handle with dull finish....
Delicate strong curved serrated tips. Serrated handle with dull finish....
1 x 2 teeth, cross serrated 5 mm 60 degree angled platform. Round knurled handle with polished finish....
Two 2.75 mm long tips separated 1 mm with 1 x 2 teeth. Serrated handle with dull finish....
Medicine Products: